Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
To satisfy your curiosity, my order was filled at 10:19:30 am, and I have pending order below that. Actually my earlier order at $1.75 never got filled despite some filled below that price.
Yes indeed. MMs knew and had to dispose those shares one way or the other. But there is an aftermath psychological impact which needs to be repaired.
Either a big fund/hedge takes the advantage to buy large sums of shares, or another positive news
Then we will make a full recover and plus.
It looked scary at the beginning of trading today but actually it has been a normal trading day to accommodate a few million new shares, which most likely are from almost-depleted-warrant exercising and selling into the market [most warrants are suspended until Nov, Dec, and next Jan]
We don't know this as retail investors, but big guys particularly MMs who know sooner or later they have to accommodate those few millions of shares, and they chose today as there is a mention of nwbo in a positive news report.
Of course, in event like this there are always carried away transactions from stop loss, short fanning the fire, and MMs of course want to own the shares at less costly as possible.
The story ends.
[If we are not recovering today, it will be soon, as psychologically such event always has a damage to the general market]
[I bought more shares around $1.87 today]
It becomes more and more looking like the recent sharp share price increase is in a big part the result of naked short covering which is ongoing and in a mini-scale:
1) A few very revealing and positive signs leading to almost a certainty that the trial will be successful, including Flaskswork acquisition, endpoint changes, EU buyin, etc.;
2) Ever increased awareness as a result of 1);
3) As share price appreciates continually day after day, it generates more awareness in the general market. The hedges who have participated in previous financing may add to their positions, and there may be a few new hedges who have been also onboard; and
4) Of course, Topline data any day now, which should be a slogan for the time being.
But, a Big But, according to my observation, the scale and trend of the volumes traded recently cannot account for all the above. Yes there has been definitely short covering, namely, those legally shorted (about 18 million as of 30 September) short covering,
But I strongly suspect it is most likely the recent sharp share price appreciation is in most part the result of naked short covering from the naked short wolfpack. According to the past estimate of Les, there could be well over 200 million naked short shares.
As a result, considering the continued increased market awareness and the much larger part of the naked shorted shares which have not yet been covered, the ongoing share price appreciation will continue.
Then, the topline data will be announced. If the results are as good as we have expected, there will be a further huge market awareness and shock in the market, not only does the short have to cover at any cost but there will be a huge unmed demand for shares from both the general market in general and hedge funds and institutions in specific (with risks removed, they will be readily onboard).
Above is just a touch of pure technicals. By now we should all know the huge potential of DCVax platform, and what we should expect if there is a buyout in terms of price.
Welcome new bloods, bye bye old timers!
Bye bye old timers and welcome again new comers!
It's a new world, new environment, and new dynamic for NWBO shareholders
We have had the journal article reporting blended and blinded trial data, which show promising and unprecedented results in some areas, and in general a worthy of approval data for GBM patients;
The subsequent update show data continued mature and got better and better;
then, FDA published "Demonstrating Substantial Evidence of Effectiveness for Human Drug and Biological Products Draft Guidance for Industry December 2019" https://www.fda.gov/regulatory-information/search-fda-guidance-documents/demonstrating-substantial-evidence-effectiveness-human-drug-and-biological-products, and NWBO adapted new endpoints in accordance with the new FDA guideline.
No one can get more clearer about the huge success of NWBO as of now, not only in GBM indication, but many, many beyond in the future
Now the market has to and has responded, and it's just beginning!
Bye Bye Old Timers, Welcome New Comers
Healthy and Inevitable Metabolism For
Life is Going on for Better in NWBO Land!
If you done your "de-risking," or "smart long" selling, let me know, but don't tell the short.
I have dry powder to accelerate incineration of the naked short wolfpack.
duplicated, ihub fails to handle high volume
WHAT I SAID YESTERDAY? Gap Up [Waiting a bit longer until some knee-jeering or the "smart ones" done their de-risking selling then we are up, up and up]
New endpoints, de-risk, huge awareness on the way, outright undervalued stock
Be ready for many gap up down the road!
"The significance of today's article titled "DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time" by By Joan Lappin
is Huge!!!
It's beginning of the final recognition by mainstream media in the US.
More to come! Huge Awareness!!
https://www.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/
"It is almost two years since I attended the Miami conference. I was not prepared to recommend it to you until now. I own it; Gramercy Capital and all of our clients own it. In recent weeks, NWBO has finally completed its Phase 3 trial. The data has been locked and sent off to the statisticians for evaluation"
http://www.gramercycapital.com/
Why Select Us?
Our concept is to concentrate our investments in a smaller group of stocks that we watch carefully and analyze ourselves. We work with our clients to determine the minimum number of stocks they are comfortable owning. Most choose a number between 8 and 15 stocks. Obviously, the approach enhances the impact on your portfolio of your winners. The same is true if a stock fizzles and goes down. Implicitly, this approach requires that you have the skills to do your own analysis (which we do!). It doesn't work if you must rely on an early call from a brokerage firm whose analyst might have changed his tune. And always, it must be recognized that we sometimes pick stocks that go down. However, the essence of excellent portfolio management is to find far more winners than losers.
Joan E. Lappin
Joan E. Lappin, our President and Chief Investment Officer, has 4 decades of Wall Street experience; first as a media and entertainment analyst and since 1980, as a portfolio manager. She has seen both bull markets and bear markets; and each more than once. Mrs. Lappin, who has been included in Marquis' Who's Who in the World, has managed assets for some of America's largest corporations and for high net worth individuals. Turn her decades of experience to your advantage.
Renowned as a "stock picker," Business Week has called Mrs. Lappin "an investment guru" and she has been well recognized as the subject of feature stories in such well known publications as The Wall Street Journal, Business Week, Newsweek, Barron's, Money, The New York Sun, Delta Sky Magazine, and USA Today, among many others. In February 2002, The New York Times' Sunday Business credited Mrs. Lappin with being the only analyst on Wall Street to spot phony accounting at Qwest Communications in 1998 when it was a Wall Street darling. "
Good timing
The significance of today's article titled "DEDUCED RECKONING: Northwest Biotherapeutics is finally ready for prime time" by By Joan Lappin
is Huge!!!
It's beginning of the final recognition by mainstream media in the US.
More to come! Huge Awareness!!
https://www.heraldtribune.com/story/business/2020/10/14/deduced-reckoning-northwest-biotherapeutics-ready-prime-time/3656047001/
"It is almost two years since I attended the Miami conference. I was not prepared to recommend it to you until now. I own it; Gramercy Capital and all of our clients own it. In recent weeks, NWBO has finally completed its Phase 3 trial. The data has been locked and sent off to the statisticians for evaluation"
http://www.gramercycapital.com/
Why Select Us?
Our concept is to concentrate our investments in a smaller group of stocks that we watch carefully and analyze ourselves. We work with our clients to determine the minimum number of stocks they are comfortable owning. Most choose a number between 8 and 15 stocks. Obviously, the approach enhances the impact on your portfolio of your winners. The same is true if a stock fizzles and goes down. Implicitly, this approach requires that you have the skills to do your own analysis (which we do!). It doesn't work if you must rely on an early call from a brokerage firm whose analyst might have changed his tune. And always, it must be recognized that we sometimes pick stocks that go down. However, the essence of excellent portfolio management is to find far more winners than losers.
Joan E. Lappin
Joan E. Lappin, our President and Chief Investment Officer, has 4 decades of Wall Street experience; first as a media and entertainment analyst and since 1980, as a portfolio manager. She has seen both bull markets and bear markets; and each more than once. Mrs. Lappin, who has been included in Marquis' Who's Who in the World, has managed assets for some of America's largest corporations and for high net worth individuals. Turn her decades of experience to your advantage.
Renowned as a "stock picker," Business Week has called Mrs. Lappin "an investment guru" and she has been well recognized as the subject of feature stories in such well known publications as The Wall Street Journal, Business Week, Newsweek, Barron's, Money, The New York Sun, Delta Sky Magazine, and USA Today, among many others. In February 2002, The New York Times' Sunday Business credited Mrs. Lappin with being the only analyst on Wall Street to spot phony accounting at Qwest Communications in 1998 when it was a Wall Street darling.
So the naked short wolfpack had no guts to dump 100k or more shares at the close to bring the price below $1.
Wow, broken nerve, even when Linda Powers once again sucked in doing financing.
Since this financing deal was settle in mid day of Monday according to thermo, by that time Linda had not been notified yet about topline data from statisticians.
Great, no leak yet after an almost a week of statisticians work on the data base; then maybe tomorrow.
Because no way information will not be leaked if the entire steering committee, advisory board are involved.
Gap up soon
[last post for me GL longs]
Linda should let me deal with you guys. Yes first she needs to hire me if I am willing:
The price based on the previous ten-day price is so low at about $0.71 is because it seemed you guys may have manipulated it down from $0.90s in anticipation of offering;
Linda Powers may or may not be aware EU clinicaltrial register would leak (update the site) with new ordered endpoints, which after confirmed by ander has been responsible for the recent days of share price rise from $0.70s to dollar land.
Besides the new endpoints, I believe Linda has other tricks if she is willing to divulge, to directly or indirectly contribute to further substantial share price appreciation.
So the deal you have had now at around $0.82 per share (increased from about $0.71 after recent share price surge) with whopping 30% warrants is utterly an supper good deal for you guys, again at the cost of retail investors.
For all the brilliance Linda has shown, she has one thing which consistently sucks, dealing with you guys for financing. As far as Les is concerned, he is just a clown.
below is your post I reply to:
My entities were $4M of this transaction. You may feel the purchase price was too low, but I had negotiated a $0.71 price this past Friday (using the prior 10-day trail). I signed my purchase agreement over the weekend (was waiting on a countersignature), but the company couldn’t get all other purchasers committed over the weekend. Once Monday hit, and the share price rose so strongly, Linda and Les called, apologized, but said they could no longer close at $0.71. So, credit them with a better price.
To move DCVax development forward briskly, capital is needed. If they didn’t complete a raise now, they would have to wait until after all the November milestones, and progress would slow.
Please put Smith and Adam F together into a dumpster. They have shown their irrelevance in the investment of nwbo for a long time.
One is too old to have a clear,foresight and even correct thinking while the other always has agenda being a hit man for the naked short wolfpack [without conspiring hedge shorts, he is not different than any bear posing in this board].
The chatters and discussions recently are almost all garbage except two PlusOne posts by anders2211 and ATLnsider.
Enjoy the ride in the uptrend!
Should I capitalize all blow:
How many days have the three world-known statisticians been handed over the key to the locked data?
How many days or hours do they need to produce topline or detailed listings and charts in accordance with the new SAP?
Are Linda and the experts notified with the results by now?
Can they who are in the know be all locked down and taken away their phones
Should or will the stock price goes steady up or gaps up into dollar land in a sudden or days[color=green][/color]
???
Regardless, it's now not whether it will but when
Now you are free to do whatever you want to do!
[Linda has a myriad of ways to push the stock up big, such as news of reapplying to NASDAQ, confirm EU and FDA nods to new SAP, new institutional interests, partnership deal, etc]
How many days have the three world-known statisticians been handed over the key to the locked data?
How many days or hours do they need to produce topline or detailed listings and charts in accordance with the new SAP?
Are Linda and the experts notified with the results by now?
Can they who are in the know be all locked down and taken away their phones
Should or will the stock price goes steady up or gaps up into dollar land in a sudden or days
???
Regardless, it's now not whether it will but when
Now you are free to do whatever you want to do!
Tryn2, it's impossible to know. Maybe Les or Linda has a sense on what percentage of those are held by the "unfriendlies"
If DCVax-l results show safety and efficacy, no unfriendlies regardless how many warrants they hold would make any difference as they will become insignificant in the face of a vast awakening of the market and its appetite.
In that case, if I were one of those "unfriedlies", I would definitely make a 180 degree turn, becoming a true long, because the ultimate goal of all investors, long, short, flip floppers is to make money.
And it would become easier for them to make more money by holding their warrants for a longer term, maybe years.
Of course, if we do see a short squeeze with share price increasing more than most have expected. Then, it's reasonable and rational for investors to sell a portion of their holdings, because the chance of the price will fall back is high.
I guess it will all be hinged on what the trial results will show.
BTW, if there is a leak, we will see some substantial volumes soon. The statisticians by now may have known what the topline is.
All your recent talking is just nonsense in the grand scheme of bringing the strength of DCVax platform into full play, with the most important and critical step of showing DCVax-L is effective and safe in treating GBM patients, thus showing the concept/MOA works
And that will be known within a short period of time after DL.
Investors buy stock based on both the potentials and fully diluted share counts of the underlining stock.
If the topline data shows the approval of concept, nothing you have talked about recently will make any sense.
Don't think those 200 million warrant/option holders are idiot who would be in a rush to exercise and lock profit; yes some of them would exercise part of it due to not fear of losing profit, but strategic and tactic reasons based on the situations of their individual portfolios.
When the whole market, or a big chunk of it, is salivating the huge potentials of DCVax platform, which has become a pretty much a sure thing, think what you have spewed in this board recently. That kind of talking doesn't make any sense.
Of course, people should lighten their positions if they don't believe the chance of success of DCVax-l, or rebalance their positions if they don't want to take too much of risks. All those are normal part of stock investment, particularly small biotech investment in the face of a binary event.
BTW, if warrant holders want to renegotiate an extension with the company, the company should decline because they would want to get more of it, and they already got too much at the cost of retails.
Don't think the market is stupid, which would not understand what the implications are if DCVax-L is shown both safe and efficacious in treating GBM patients.
Faced with the success, on which stock exchanges is our stock traded is really not that important. Any institutional funds will easily find a way to get around any hurdles if any, and onboard.
we all know you are "long" with menopause syndrome, and I can predict you will get over it after further aging.
Oh, the lost shares, the soured mood, the still young curve of learning about who Linda Powers is
We have left you behind at the stagnation station, and can barely hear your waning.
Fuel yourselves with rocket fuel, we can still meet at the airport in the north shore as we are moving steady at this stage lest you finally understand our fearless complex leader.
Then we can still fly together into blue sky.
Your choice!
For God sake, before today's (hard) data lock announcement it's soft data lock, and analyses.
The delay, the confusion!
Unless it's a sure thing now Linda will not commit announcing hard data lock
The soft data lock lands LL's SNO plenary spot and Late Breaker Abstract, resulted in substantial first two waves of share appreciation, along with Flaskwork acquisition.
Unless it's perfection, Linda Powers will not commit no return hard data lock. The results will be soon learned by statisticians in a few hours if the want who will forward the results to Linda Powers, etc.
The next wave of substantial share price appreciation will come, if not today, very soon.
No way there will be no leak!
It certainly doesn't mean the general public will get the results in a few hours after plugging data and running the computer, it does mean the statisticians who if they wish can get the results in a few hours of time.
From that, how things will proceed is anyone's guess. But as per the company's news, the general public is probably notified in a month or so time.
But news will be leaked in the meantime !!!
It's a mere few hours of labor to plug and get topline data from now locked data ![color=red][/color]
Exactly, there would be only a short delay from Linda's late September deadline for Topline, for which the ihubers have been hysterical since last Thursday.
And the so self-claimed longs;
The skittish, the knee-jerking, and the lost shares;
The greedy, naked short wolfpack commissioned corrupted no-guts MM with measly volumes showing weak hands;
Let alone the vast armies of constant flip flopers who at end always lose more than gain.
All will lead to a much much higher initial and lasting upward price movement
The same story will go on and on.
Who call them stupid. you are talking about specific cases and I am talking about general trend. That's a huge difference.
If you want to talk about specific cases, I bet some people also buy high and sell low.
And that small number of cases regardless is useless in our discussion.
The point being MMs manipulation which can only be successful because there always being stupid investors, skittish, knee-jerking, and because of the selfishness of constant flip floppers.
Be noted I am one of those investors who have bought their most shares at teens, twenties, and thirties, and have since averaged up.
Simply, nothing has changed despite daily mood changes in ihub regarding the success of bringing DCVax platform into market, and I believe the company has been working hard to maximize the potential of the platform, and it's understandable the process may not go as smoothly as most expected.
To that end, the company should not act like a baby sitter.
[Guess this is my last post allowed, so bye for today]
Have you noticed the date of my post? The measly volumes in a down day tell you a lot about the health of the recent days transactions -- transit, temporary, and manipulated. It cries out BUY, BUY, AND BUY!
MMs can succeed in bringing the price down some because there are always too many stupid investors, skittish, some genuine duo to lack of experience, or out of nature, but more are pathetic thinking they can constantly flip flop, selfish and at end always lose more.
I feel smart because of these skittish kids, and the work of the naked short wolfpack.
I know I can make much more money because of them, hence averaging up.
Thanks for giving me more cheap shares. Just bought two batches around 0.7
Some people are just pure stupid -- the blinded data already show DCVax-L will be approved, but with improved, better data to be expected from unblinding, the approval process may be speedier and the market success may be grenadier.
Have $50k more to put in work today!
Bottom line:
If the trial fails, we would have been notified by now;
Either the delay is related to regulatory process/discussion or not, or behind the scene bargaining of big P or Ps with the company, it will pan out in due time;
DI is out of loop, give the guy a break;
It more and more looks like some knee jerking longs will lose out big, along with the unfortunate and pathetic naked short wolfpack during the process.
Just relax, observing, or add some more shares here and there when the price is depressed, or simply go take a break.
Spartex, it's Chinese, and Chinese often say that with optimism.
Even with FDA's involvement in this stage, all the announcment/PRs will fall onto company's shoulder. FDA as usual works behind the scene.
With that said, it's still likely the next update we will see is Topline data announcement despite most think it is delayed.
In my decades of biotech investment, I have never ever heard statisticians of a pivotal Phase 3 trial need several weeks to analyze locked data, and never ever heard the underlined company after receiving report from statisticians, needs several weeks to consult with their experts before the company is ready for Topline data announcement.
Nor have I ever heard a company needs one or two months to have a hard data lock when every set of data has been collected.
It's usually a two months to three months time from a company reaches its designed endpoint counts, either progression free survival or overall survival, and you name it, to topline announcement, and if the trial fails, the announcement comes much sooner.
I once lost about $200,000 in two days when I bought low and gambled the underlined company, which I didn't believe it had any chance to succeed, and the company just announced it reached endpoint counts, and estimated it would need 2-3 months to get topline data ready a month earlier. The share price had been dropped like a free falling rock, and I thought I was safe for a quick profit selling into the anticipated rebound of share price well before the two month deadline. Well only two days after I bought, in the 45th days, the company suddenly announced it failed in the trial.
Now back to nwbo, it is of course a totally different story. Because its strong science foundation, positive blinded data backing and stalled SOC, most investors believe its DCVax-L trial for GBM patients will be a success, the difference being how success it will be.
Despite all the above, why is the company so conservative and even out-of-bounds in its timeline estimation to get topline data, and it may have not yet had data locked today?
The only conclusion I can come with is more or less the involvement of the government authorities such as FDA. In normal cases, FDA won't participate during this stage; if the trial is a failure, FDA won't spend a second to get involved, particularly when the pandemic has exhausted its time.
In addition, there is also a suggestion by Dave Innes in a recent conversation with one poster about government involvement, and the yet-to-finalized FDA guideline which seems tailored in some way to our DCVax-L trial.
Well, it seems there is a reason of the out-of-bounds timeline and continued confusion about it!
Marzan you are absolutely right that companies should not irk the FDA in any way and form because FDA is vindictive. I guess there is no company which has done a better job than nwbo under Linda Powers, particularly considering the suspected malicious act involving FDA in the partial halt for screening new patients years ago.
Exactly because of that, the relationship between nwbo and FDA has been in the mend ever since, culminating on the lift of the partial halt, which took place years ago later.
Then the suspected involvement of nwbo in the new draft guidance of FDA.
Perhaps FDA has been actually closer than one would suspect in guiding the concluding of our Ph3 DCVax-L trial, sort of as its own experiment/test for the new guidance; perhaps the finalization of its new guidance is pending the conclusion of Ph3 DCVax-L trial.
Anyhow, if FDA's involvement in the Ph3 DCVax-L trial in this stage is true, that would be really interesting.
In addition, I guess maybe FDA has had all the documents necessary for an approval (condition or not) except the final trial results, and of course a formal application.
Thanks for pointing out that, but the point of my post regarding suggested government involvement and possible consequence, not only topline data announcement but also maybe conditional approval at the same time or shortly after topline data announcement still stands excluding Les's last year TV show (or any of Les's TV show ever existing).
Why involve the government in this stage of DL and topline preparation? Perhaps, IDH data, etc, is requested by FDA, and the company has been sitting on the backbench for quite some time.
When everything is checked and ready. We will be notified.
Again, maybe not just DL, Topline data, there is more to come!
Amazing development is unfolding right before our eyes if RuleofK's conversation with DI regarding DI's suggestion of government involvement in this stage of DL and Lykiri provided bigbiz show dated today, 26 September which, unlike all the previous shows which predicts the timing of DL and Topline data, in today's Les' interview with Bigbiz show, there is no mentioning of either DL or Topline data.
Coupled these with two shift overtime working at Sawston to make available of sizable manufacturing capacity by October, a very clear picture emerges:
When Topline data is announced either as scheduled by the end of September or in couple of weeks, it may accompany a conditional FDA approval as well, if FDA has involved in this process, which can readily explain why the confusion and why the delay in data lock, etc. I guess FDA is unblinded, and LL is semi-unblinded, and as of today the company is still blinded. And FDA is the one who gives instruction.
That is what has come to my mind at the time being. BTW, Les' excitement in today's show about the huge potential of DCVax platform is genuine, very much unlike his makeup.
Wow I am happy I have added to my position last week, and intended to add more in the coming weeks.
This is my last post today. GLTA!
“If it's bitter at the start, then it's sweeter in the end.”
? Madonna
It seems most posters in this board are traders, flip flopers unfortunately judged by their posts in this board. The company has been very consistent in timeline, i.e., ambiguity for a reason.
Some have got the words via phone or email indicating the company will announce data lock, of course the hard data lock, aka the final data lock, while in prerecorded presentation and other information strongly suggest topline data in later the month of September.
Even the "later in the month of September" itself in a complete sentence is ambiguity in hindsight.
The point has always been and still is today that the company, though confident in positive outcome of the trial, has only this chance to get it right to show its worth, and it cannot afford to mess it up. And if the company has two winning cards, it should not rash to announce one card while messed up with the other.
From the repeated goal post moving in the past to today's intentional ambiguity in the timing of topline data, the company has been very transparent actually and consistent. So it is a bit of worrisome that so many investors have been surprised by Les's unfortunate prerecorded bar show, let alone complaining and screaming afterwards. If there is one thing the company needs to change its behavior, that would be to ban Les from ever appearing in such unfortunate show. Grow up and prepare for big-time prime TV show instead!
The ultimate goals of the company and ours are the same: to first successfully conclude the Phase 3 DCVax-L trial for GMB with at least good enough results for regulatory approvals in four countries, and second to bring the then concept-approved DCVax platform into full capacity to treat all operable and inoperable solid tumors.
Then how come the repeated overreaction because of too many flippant flip flops. During such periods, unfortunately some have fell for the prey of the greedy wall street/stock market. After all, what really is the significant difference between a few pennies/dimes' advantage in share price and a share price which will be $5 or more in a short term from within several weeks to a month or two if you would?
Next time, calm down boys and girls! No shaken up, take advantage if such situation repeats to add in your positions if you want more in your portfolio. Let the naked short wolfpack and other agitators pay the costly price in the end.
Remember the company needs a wiggle room, which is for the good of all us investors, and most importantly for the future patients.
It is those who play with fire will get burned.
God blesses topline data tonight or Monday morning. That would be real fun!
I know it's unlikely after Les' clown show, but it's never impossible with God.
Bought three batches of shares today!
FOR PEOPLE WHO DON'T THINK LINDA HAS A REAL PEEK OF DATA AND IS PRETTY CONFIDENCE IN BRINGING THIS PLATFORM TO PATIENTS AS MANY AS POSSIBLE, THEN IT'S NO CURE FOR YOU. SO WHY DELAY, IT'S PERFECTION!
BUY AS MANY AS YOU CAN AFFORD. ITS NO BRAINER
By noon's time we will clear all the traders and some opportunistic shorts, then that's the time for "an update."
BTW, where are those big guys who are holding 100 million shares/warrant?
Can they drop 100k cash to buy the dip? Or they are the guys making the dip?
[Just confirm another batch of shares bought around 0.73]
[A little more than 2 million share transaction made this 5 pennies of drop. pathetic]
Aimed at 0.77 yesterday, and got filled today around 0.74
Like volatility because I have made available of funds. Let's go Linda.
Never know if update = topline? If not, can wait for a little while longer
Make money work more profitably perhaps
this trend of past several days definitely kill traders
Next is the naked short wolfpack, which is always in Linda's mind, let alone Les's